These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 12892163
1. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F. Acta Paediatr; 2003 Jul; 92(7):827-35. PubMed ID: 12892163 [Abstract] [Full Text] [Related]
2. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone. Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F. Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571 [Abstract] [Full Text] [Related]
3. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, Visser GH, van Bel F, Heijnen CJ. Pediatrics; 2008 Apr; 121(4):e870-8. PubMed ID: 18381516 [Abstract] [Full Text] [Related]
4. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001146. PubMed ID: 24825456 [Abstract] [Full Text] [Related]
5. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents. ter Wolbeek M, de Sonneville LM, de Vries WB, Kavelaars A, Veen S, Kornelisse RF, van Weissenbruch M, Baerts W, Liem KD, van Bel F, Heijnen CJ. Psychoneuroendocrinology; 2013 Jul 13; 38(7):975-86. PubMed ID: 23107421 [Abstract] [Full Text] [Related]
6. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up. de Vries WB, Karemaker R, Mooy NF, Strengers JL, Kemperman H, Baerts W, Veen S, Visser GH, Heijnen CJ, van Bel F. Arch Pediatr Adolesc Med; 2008 Aug 13; 162(8):738-44. PubMed ID: 18678806 [Abstract] [Full Text] [Related]
7. Dexamethasone but not the equivalent doses of hydrocortisone induces neurotoxicity in neonatal rat brain. Feng Y, Kumar P, Wang J, Bhatt AJ. Pediatr Res; 2015 May 13; 77(5):618-24. PubMed ID: 25665056 [Abstract] [Full Text] [Related]
8. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ, National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med; 2001 Jan 11; 344(2):95-101. PubMed ID: 11150359 [Abstract] [Full Text] [Related]
9. Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents. Ter Wolbeek M, Kavelaars A, de Vries WB, Tersteeg-Kamperman M, Veen S, Kornelisse RF, van Weissenbruch M, Baerts W, Liem KD, van Bel F, Heijnen CJ. Brain Behav Immun; 2015 Mar 11; 45():128-38. PubMed ID: 25449580 [Abstract] [Full Text] [Related]
10. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Vermont Oxford Network Steroid Study Group. Pediatrics; 2001 Sep 11; 108(3):741-8. PubMed ID: 11533345 [Abstract] [Full Text] [Related]
11. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001145. PubMed ID: 24825542 [Abstract] [Full Text] [Related]
12. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Warmerdam LA, van Wezel-Meijler G, de Vries LS, Groenendaal F, Steggerda SJ. Neonatology; 2023 May 13; 120(5):615-623. PubMed ID: 37379806 [Abstract] [Full Text] [Related]
13. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA, Harrison M, Clark RH. Pediatrics; 2009 Aug 13; 124(2):673-9. PubMed ID: 19620192 [Abstract] [Full Text] [Related]
14. Effects of neonatal corticosteroid treatment on hippocampal synaptic function. Huang CC, Lin HR, Liang YC, Hsu KS. Pediatr Res; 2007 Sep 13; 62(3):267-70. PubMed ID: 17622955 [Abstract] [Full Text] [Related]
16. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G. Pediatrics; 2002 Jun 13; 109(6):e85. PubMed ID: 12042579 [Abstract] [Full Text] [Related]
17. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial. Bloomfield FH, Knight DB, Harding JE. J Pediatr; 1998 Sep 13; 133(3):395-400. PubMed ID: 9738724 [Abstract] [Full Text] [Related]
18. Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit. Röhr SB, Sauer H, Gottschling S, Abdul-Khaliq H, Gortner L, Nunold H, Gräber S, Meyer S. Swiss Med Wkly; 2014 Sep 13; 144():w13954. PubMed ID: 24706463 [Abstract] [Full Text] [Related]
19. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. Ramanathan R, Siassi B, deLemos RA. J Perinatol; 1995 Sep 13; 15(3):178-82; quiz 183-4. PubMed ID: 7666264 [Abstract] [Full Text] [Related]
20. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up. Rademaker KJ, de Vries LS, Uiterwaal CS, Groenendaal F, Grobbee DE, van Bel F. Arch Dis Child Fetal Neonatal Ed; 2008 Jan 13; 93(1):F58-63. PubMed ID: 17848504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]